Literature DB >> 25711473

Ten old antibiotics that will never disappear.

Matteo Bassetti1, Matthew E Falagas2,3,4, Marin Kollef5.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 25711473     DOI： 10.1007/s00134-015-3705-5

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  13 in total

Review 1.  MRSA: the first half century.

Authors:  Robert C Moellering
Journal:  J Antimicrob Chemother       Date:  2011-10-18       Impact factor: 5.790

2.  Inhaled colistin as adjunctive therapy to intravenous colistin for the treatment of microbiologically documented ventilator-associated pneumonia: a comparative cohort study.

Authors:  I P Korbila; A Michalopoulos; P I Rafailidis; D Nikita; G Samonis; M E Falagas
Journal:  Clin Microbiol Infect       Date:  2009-09-02       Impact factor: 8.067

Review 3.  Contemporary unconventional clinical use of co-trimoxazole.

Authors:  E Goldberg; J Bishara
Journal:  Clin Microbiol Infect       Date:  2011-08-18       Impact factor: 8.067

Review 4.  Treatment of syphilis: a systematic review.

Authors:  Meredith E Clement; N Lance Okeke; Charles B Hicks
Journal:  JAMA       Date:  2014-11-12       Impact factor: 56.272

5.  Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary.

Authors:  Catherine Liu; Arnold Bayer; Sara E Cosgrove; Robert S Daum; Scott K Fridkin; Rachel J Gorwitz; Sheldon L Kaplan; Adolf W Karchmer; Donald P Levine; Barbara E Murray; Michael J Rybak; David A Talan; Henry F Chambers
Journal:  Clin Infect Dis       Date:  2011-02-01       Impact factor: 9.079

Review 6.  Association between vancomycin minimum inhibitory concentration and mortality among patients with Staphylococcus aureus bloodstream infections: a systematic review and meta-analysis.

Authors:  Andre C Kalil; Trevor C Van Schooneveld; Paul D Fey; Mark E Rupp
Journal:  JAMA       Date:  2014-10-15       Impact factor: 56.272

Review 7.  Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum beta-lactamase producing, Enterobacteriaceae infections: a systematic review.

Authors:  Matthew E Falagas; Antonia C Kastoris; Anastasios M Kapaskelis; Drosos E Karageorgopoulos
Journal:  Lancet Infect Dis       Date:  2010-01       Impact factor: 25.071

Review 8.  Do we still need the aminoglycosides?

Authors:  Emanuele Durante-Mangoni; Alexandros Grammatikos; Riccardo Utili; Matthew E Falagas
Journal:  Int J Antimicrob Agents       Date:  2008-10-30       Impact factor: 5.283

9.  Evaluation of High-Dose Daptomycin Versus Vancomycin Alone or Combined with Clarithromycin or Rifampin Against Staphylococcus aureus and S. epidermidis in a Novel In Vitro PK/PD Model of Bacterial Biofilm.

Authors:  Ashley D Hall Snyder; Celine Vidaillac; Warren Rose; John P McRoberts; Michael J Rybak
Journal:  Infect Dis Ther       Date:  2014-12-18

Review 10.  Cotrimoxazole - optimal dosing in the critically ill.

Authors:  Glen R Brown
Journal:  Ann Intensive Care       Date:  2014-04-28       Impact factor: 6.925
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.